CClinicalTrials.gg
CompletedNCT02757690Updated May 2, 2016

Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy

A Phase 4 interventional study of 3-dimensional distal pancreatectomy and 2-dimensional distal pancreatectomy in Benign Neoplasm of Body of Pancreas and Benign Neoplasm of Tail of Pancreas, sponsored by Asan Medical Center. Completed. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-05-02.

Sponsored by Asan Medical Center · Phase 4 and Interventional

Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Study summary

Traditionally, laparoscopy has been based on 2-dimensional (2D) imaging, which has represented a considerable challenge for those approaching this technique. Thus, 3-dimensional (3D) visualization technology for laparoscopy has been proposed, since the early 1990s, as a way to facilitate laparoscopic performance. However, early 3D laparoscopic technology was limited in terms of image quality, so that its use had not been implemented. More recently, industry has developed novel 3D systems where the imaging is similar to stereoscopic vision, in which the depth perception is achieved by different unique images received by each eye. Thus, more recent studies have suggested a possible advantage provided by these new 3D systems during laparoscopic performance. However, comparative assessments of new generation 3D vs 2D laparoscopy remain limited, especially in the hepatobiliary and pancreatic field.

To assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic distal pancreatectomy.

Read the detailed description

Procedures

  1. the investigators will take the patient consent for this clinical trial.
  2. The participants will be divided with two groups with block randomized method
  3. Skillful pancreatic surgeon will perform 2D or 3D laparoscopic distal pancreatectomy.
  4. The participants will be monitor the intraoperative and postoperative course.

Data collection

  1. operation video : operation time, number of errors (missed grasp, loss of material)

    1. Segmental operation time according to procedure
    2. Numbers of errors during operation
  2. clinical parameters:

    1. Blood examination : complete blood count (hemoglobin, white blood cell count), amylase, lipase, etc.
    2. Radiological examination: X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), etc
    3. Medical records : hospital stay after operation, the time to eating, pathologic examination
  3. Subjective scoring in the view of operator, 1st assist.

    1. Scoring for imaging quality
    2. Scoring for harms of 3D/2D laparoscopic system
    3. Scoring for overall demand
02

Conditions studied

  • Benign Neoplasm of Body of Pancreas
  • Benign Neoplasm of Tail of Pancreas
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 60 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Asan Medical Center is the lead sponsor of 562 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • BMI > 30 (Kg/m2)
  • History of severe or recurrent pancreatitis
  • Mass size > 10cm
  • History of low abdomen major operation
  • Additional resection for extra-pancreatic organ

Exclusion criteria

Exclusion Criteria:

  • Participants refusal.
  • Additional resection dependent on pathological examination in intraoperative or postoperative period.
05

Study design

Phase
Phase 4
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    2-dimenasional distal pancreatectomy

    device: 2 dimensional laparoscopy of Olympus

    Device: 2-dimensional distal pancreatectomy

  • Experimental
    3-dimenasional distal pancreatectomy

    device : 3 dimensional laparoscopy of Olympus

    Device: 3-dimensional distal pancreatectomy

Interventions

  • Device3-dimensional distal pancreatectomy

    3D laparoscopy

    Also known as: 3D

  • Device2-dimensional distal pancreatectomy

    2D laparoscopy

    Also known as: 2D

06

What researchers measure

Primary outcomes

  1. Operation time

    The unedited videos of the operations will be assessed from start to end of the operation by two clinicians. The average of operation time will be compare according to 2D versus 3D laparoscopic system.

    Time frame: expected duration: 200mins (for each operation)

Secondary outcomes

  1. Numbers of errors during operation

    The investigators will check the error number of operator during operation with review the video record of the operation

    Time frame: During operation (expected duration: 200mins)

  2. Subjective scoring in the view of operator, 1st assist

    The investigators will check the subjective scoring of operator and 1st assist during operation. For example, depth perception, sharpness, visual strain, headache, etc.

    Time frame: During operation (expected duration: 200mins)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02757690
Lead sponsor
Asan Medical Center
Collaborators
Olympus
Responsible party
Song Cheol Kim (professor, Asan Medical Center) — Principal investigator
First posted
May 2, 2016
Start date
Jan 2015
Primary completion
Feb 2016
Completion
Feb 2016
Last update
May 2, 2016

Study contacts

Songcheol Kim, MD PhD
principal investigator · Asan Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion